Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents

  • John S. Werry
  • Michael G. Aman

Table of contents

  1. Front Matter
    Pages i-xxxi
  2. General Principles

    1. Front Matter
      Pages 1-1
    2. James William Paxton, Michael Dragunow
      Pages 23-55
    3. Kenneth D. Gadow
      Pages 57-74
    4. Alan J. Zametkin, Emily M. Yamada
      Pages 75-97
    5. Ronald Schouten, Kenneth S. Duckworth
      Pages 161-178
    6. Kelly Botteron, Barbara Geller
      Pages 179-201
  3. Specific Drugs

    1. Front Matter
      Pages 203-203
    2. Russell A. Barkley, George J. DuPaul, Anthony Costello
      Pages 205-237
    3. John O. Viesselman, Shahnour Yaylayan, Elizabeth B. Weller, Ronald A. Weller
      Pages 239-268
    4. Magda Campbell, Nilda M. Gonzalez, Monique Ernst, Raul R. Silva, John S. Werry
      Pages 269-296
    5. Alan S. Unis, Jon Mcclellan
      Pages 297-319
    6. Richard O. Carpenter, Eileen P. G. Vining
      Pages 321-346
    7. Brent Waters, Antony Milch
      Pages 347-371
    8. C. Keith Conners
      Pages 373-389
    9. John s. Werry, Michael G. Aman
      Pages 391-415
  4. Back Matter
    Pages 417-440

About this book


information. This book aims to do this for practitioners, professionals in health, welfare, and education, and interested laypersons, including parents. This is no easy task, since the levels of technical knowledge vary from that of the special education teacher seeking information about the drugs that many such pupils will be receiving, to that of the modern young child and adolescent psychiatrist whose grasp of the difficult fields of pharmacokinetics (how drugs are absorbed, distributed, and eliminated) and neurotransmitter physiology (via which most psychoactive drugs work) is daunting to the editors, who grew up in the bucolic clinical-empirical era. Inevitably there are sections of the book that will prove too technical for any except the medically qualified, but considerable effort has been applied to make much of the text, especially that discussing the clinical uses and side effects of the drugs, comprehensible to anyone used to getting information by reading. We also take comfort in the fact that many of the major contributions in pediatric psychophar­ macology have been made by nonmedical professionals, notably psychologists, suggesting that an audience beyond the medically qualified is practicable. One other problem confronted us-whether to organize the book by psycho­ pathological symptoms (e.g., hyperactivity) and disorders (e.g., autism) or by drugs.


Anorexia nervosa Bulimia nervosa Syndrom attention attention deficit hyperactivity disorder (ADHD) bipolar disorder depression diagnosis epidemiology hyperactivity identity mood disorder pharmacokinetics psychiatric disorder psychiatry

Editors and affiliations

  • John S. Werry
    • 1
  • Michael G. Aman
    • 2
  1. 1.University of AucklandAucklandNew Zealand
  2. 2.The Nisonger Center for Mental Retardation and Developmental DisabilitiesThe Ohio State UniversityColumbusUSA

Bibliographic information

  • DOI
  • Copyright Information Plenum Publishing Corporation 1993
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-0-306-44389-3
  • Online ISBN 978-1-4615-2884-5
  • Buy this book on publisher's site